Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypobetalipoproteinemia, Familial, Apolipoprotein B | 1 | 2019 | 1 | 0.690 |
Why?
|
| Hypobetalipoproteinemias | 1 | 2019 | 11 | 0.680 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2022 | 583 | 0.600 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 382 | 0.520 |
Why?
|
| Dyslipidemias | 2 | 2022 | 890 | 0.510 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 1046 | 0.470 |
Why?
|
| Triglycerides | 2 | 2022 | 2469 | 0.410 |
Why?
|
| Cardiology | 1 | 2022 | 1703 | 0.380 |
Why?
|
| Self Care | 1 | 2016 | 789 | 0.380 |
Why?
|
| Exercise | 4 | 2023 | 5745 | 0.380 |
Why?
|
| Hypercholesterolemia | 1 | 2017 | 1154 | 0.340 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 2065 | 0.340 |
Why?
|
| Anticholesteremic Agents | 1 | 2017 | 985 | 0.330 |
Why?
|
| Cholesterol, LDL | 5 | 2024 | 2407 | 0.330 |
Why?
|
| Lipids | 2 | 2022 | 3328 | 0.330 |
Why?
|
| Life Style | 2 | 2022 | 3858 | 0.320 |
Why?
|
| Poverty | 2 | 2018 | 2639 | 0.300 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3308 | 0.290 |
Why?
|
| Health Behavior | 2 | 2018 | 2615 | 0.280 |
Why?
|
| Patient Compliance | 1 | 2016 | 2680 | 0.270 |
Why?
|
| Guideline Adherence | 2 | 2016 | 2275 | 0.270 |
Why?
|
| Adolescent | 13 | 2024 | 86765 | 0.250 |
Why?
|
| Medication Adherence | 1 | 2016 | 2134 | 0.250 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 15621 | 0.240 |
Why?
|
| Hypertension | 3 | 2023 | 8496 | 0.240 |
Why?
|
| Nutrition Surveys | 2 | 2023 | 1697 | 0.220 |
Why?
|
| Blood Component Removal | 1 | 2024 | 128 | 0.220 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2023 | 251 | 0.190 |
Why?
|
| Atherosclerosis | 1 | 2017 | 3503 | 0.180 |
Why?
|
| Obesity | 1 | 2023 | 12806 | 0.180 |
Why?
|
| Mass Screening | 1 | 2016 | 5397 | 0.180 |
Why?
|
| Child | 8 | 2024 | 78998 | 0.170 |
Why?
|
| Telemedicine | 1 | 2016 | 2948 | 0.170 |
Why?
|
| Homozygote | 1 | 2024 | 1784 | 0.160 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5839 | 0.150 |
Why?
|
| Goals | 1 | 2022 | 701 | 0.150 |
Why?
|
| Cholesterol, HDL | 2 | 2022 | 1815 | 0.140 |
Why?
|
| Private Sector | 1 | 2019 | 398 | 0.130 |
Why?
|
| Financing, Government | 1 | 2019 | 466 | 0.130 |
Why?
|
| American Heart Association | 1 | 2020 | 1070 | 0.130 |
Why?
|
| Environment Design | 1 | 2017 | 173 | 0.130 |
Why?
|
| Sex Factors | 2 | 2019 | 10455 | 0.120 |
Why?
|
| Consensus | 1 | 2024 | 3034 | 0.120 |
Why?
|
| Aorta | 1 | 2022 | 2033 | 0.120 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2016 | 444 | 0.110 |
Why?
|
| United States | 6 | 2023 | 71442 | 0.100 |
Why?
|
| Humans | 17 | 2024 | 752341 | 0.100 |
Why?
|
| Diabetic Angiopathies | 1 | 2016 | 821 | 0.100 |
Why?
|
| Body Mass Index | 2 | 2019 | 12796 | 0.090 |
Why?
|
| Young Adult | 3 | 2023 | 57629 | 0.090 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 779 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2019 | 6360 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2018 | 1596 | 0.080 |
Why?
|
| Residence Characteristics | 1 | 2017 | 2020 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2018 | 1775 | 0.070 |
Why?
|
| Massachusetts | 1 | 2019 | 8707 | 0.070 |
Why?
|
| Mental Health | 1 | 2020 | 3150 | 0.070 |
Why?
|
| State Health Plans | 1 | 2007 | 220 | 0.060 |
Why?
|
| Phenotype | 2 | 2024 | 16439 | 0.060 |
Why?
|
| Adult | 4 | 2023 | 216913 | 0.060 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2007 | 334 | 0.060 |
Why?
|
| Hyperlipoproteinemia Type I | 1 | 2024 | 11 | 0.060 |
Why?
|
| Echocardiography | 1 | 2016 | 4950 | 0.060 |
Why?
|
| Inflammation | 1 | 2023 | 10690 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2022 | 79127 | 0.050 |
Why?
|
| Age Factors | 1 | 2019 | 18297 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 6116 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2024 | 64245 | 0.040 |
Why?
|
| Lipoprotein(a) | 1 | 2024 | 494 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2024 | 884 | 0.040 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2024 | 395 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 41659 | 0.040 |
Why?
|
| Health Care Reform | 1 | 2007 | 1242 | 0.040 |
Why?
|
| District of Columbia | 1 | 2017 | 159 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2023 | 8467 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 25535 | 0.030 |
Why?
|
| Male | 3 | 2019 | 354881 | 0.030 |
Why?
|
| Bicycling | 1 | 2017 | 175 | 0.030 |
Why?
|
| Transportation | 1 | 2017 | 215 | 0.030 |
Why?
|
| Female | 3 | 2019 | 386053 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 53807 | 0.030 |
Why?
|
| Counseling | 1 | 2022 | 1542 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 21808 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2024 | 2236 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2023 | 2561 | 0.020 |
Why?
|
| Walking | 1 | 2017 | 1173 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 73412 | 0.020 |
Why?
|
| Cost Sharing | 1 | 2007 | 405 | 0.010 |
Why?
|
| Government Regulation | 1 | 2007 | 523 | 0.010 |
Why?
|
| Efficiency, Organizational | 1 | 2007 | 689 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 17648 | 0.010 |
Why?
|
| Algorithms | 1 | 2017 | 13900 | 0.010 |
Why?
|
Concepts
(92)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_